WallStSmart

Nomura Holdings Inc ADR (NMR)vsHyperliquid Strategies Inc Common Stock (PURR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 24641677% more annual revenue ($2.33T vs $9.46M). PURR leads profitability with a 3230.0% profit margin vs 17.3%. PURR trades at a lower P/E of 3.8x. NMR earns a higher WallStSmart Score of 84/100 (A-).

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

PURR

Buy

58

out of 100

Grade: C

Growth: 4.3Profit: 7.0Value: 6.7Quality: 5.0

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

PURR4 strengths · Avg: 9.5/10
P/E RatioValuation
3.8x10/10

Attractively priced relative to earnings

Profit MarginProfitability
3230.0%10/10

Keeps 3230 of every $100 in revenue as profit

Operating MarginProfitability
9595.0%10/10

Strong operational efficiency at 9595.0%

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Areas to Watch

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

PURR3 concerns · Avg: 3.7/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bull Case : PURR

The strongest argument for PURR centers on P/E Ratio, Profit Margin, Operating Margin. Profitability is solid with margins at 3230.0% and operating margin at 9595.0%.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Bear Case : PURR

The primary concerns for PURR are Revenue Growth, EPS Growth, Return on Equity.

Key Dynamics to Monitor

NMR profiles as a growth stock while PURR is a value play — different risk/reward profiles.

NMR is growing revenue faster at 31.2% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 58/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Hyperliquid Strategies Inc Common Stock

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Hyperliquid Strategies Inc., through its subsidiary, is a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?